Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Karen Elkind‐Hirsch, Neil Chappell, Donna Shaler, John Storment, Drake E. Bellanger
Topics & Concepts
Polycystic ovaryMedicineLiraglutideFree androgen indexHyperandrogenismPlaceboInternal medicineEndocrinologyWeight lossLipid profileRandomized controlled trialMetabolic syndromeInsulin resistanceObesityDiabetes mellitusType 2 diabetesAlternative medicinePathologyDiabetes Treatment and ManagementOvarian function and disordersPharmacology and Obesity Treatment